138 related articles for article (PubMed ID: 29269086)
1. KISS1 tumor suppressor restricts angiogenesis of breast cancer brain metastases and sensitizes them to oncolytic virotherapy in vitro.
Platonov ME; Borovjagin AV; Kaverina N; Xiao T; Kadagidze Z; Lesniak M; Baryshnikova M; Ulasov IV
Cancer Lett; 2018 Mar; 417():75-88. PubMed ID: 29269086
[TBL] [Abstract][Full Text] [Related]
2. Combinatorial strategies based on CRAd-IL24 and CRAd-ING4 virotherapy with anti-angiogenesis treatment for ovarian cancer.
Ashshi AM; El-Shemi AG; Dmitriev IP; Kashentseva EA; Curiel DT
J Ovarian Res; 2016 Jun; 9(1):38. PubMed ID: 27349517
[TBL] [Abstract][Full Text] [Related]
3. Astrocytes promote progression of breast cancer metastases to the brain via a KISS1-mediated autophagy.
Kaverina N; Borovjagin AV; Kadagidze Z; Baryshnikov A; Baryshnikova M; Malin D; Ghosh D; Shah N; Welch DR; Gabikian P; Karseladze A; Cobbs C; Ulasov IV
Autophagy; 2017; 13(11):1905-1923. PubMed ID: 28981380
[TBL] [Abstract][Full Text] [Related]
4. 5/35 fiber-modified conditionally replicative adenovirus armed with p53 shows increased tumor-suppressing capacity to breast cancer cells.
He X; Liu J; Yang C; Su C; Zhou C; Zhang Q; Li L; Wu H; Liu X; Wu M; Qian Q
Hum Gene Ther; 2011 Mar; 22(3):283-92. PubMed ID: 20846024
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA 345 (miR345) regulates KISS1-E-cadherin functional interaction in breast cancer brain metastases.
Ulasov I; Borovjagin A; Fares J; Yakushov S; Malin D; Timashev P; Lesniak MS
Cancer Lett; 2020 Jul; 481():24-31. PubMed ID: 32246957
[TBL] [Abstract][Full Text] [Related]
6. Reduced metastasis-suppressor gene mRNA-expression in breast cancer brain metastases.
Stark AM; Tongers K; Maass N; Mehdorn HM; Held-Feindt J
J Cancer Res Clin Oncol; 2005 Mar; 131(3):191-8. PubMed ID: 15592684
[TBL] [Abstract][Full Text] [Related]
7. Clinical significance of KISS1 protein expression for brain invasion and metastasis.
Ulasov IV; Kaverina NV; Pytel P; Thaci B; Liu F; Hurst DR; Welch DR; Sattar HA; Olopade OI; Baryshnikov AY; Kadagidze ZG; Lesniak MS
Cancer; 2012 Apr; 118(8):2096-105. PubMed ID: 21928364
[TBL] [Abstract][Full Text] [Related]
8. MT1-MMP silencing by an shRNA-armed glioma-targeted conditionally replicative adenovirus (CRAd) improves its anti-glioma efficacy in vitro and in vivo.
Ulasov I; Borovjagin AV; Kaverina N; Schroeder B; Shah N; Lin B; Baryshnikov A; Cobbs C
Cancer Lett; 2015 Sep; 365(2):240-50. PubMed ID: 26052095
[TBL] [Abstract][Full Text] [Related]
9. Different therapeutic effects of distinct KISS1 fragments on breast cancer in vitro and in vivo.
Song GQ; Zhao Y
Int J Oncol; 2013 Oct; 43(4):1219-27. PubMed ID: 23900657
[TBL] [Abstract][Full Text] [Related]
10. Combining high selectivity of replication via CXCR4 promoter with fiber chimerism for effective adenoviral oncolysis in breast cancer.
Stoff-Khalili MA; Rivera AA; Stoff A; Michael Mathis J; Rocconi RP; Matthews QL; Numnum MT; Herrmann I; Dall P; Eckhoff DE; Douglas JT; Siegal GP; Zhu ZB; Curiel DT
Int J Cancer; 2007 Feb; 120(4):935-41. PubMed ID: 17131341
[TBL] [Abstract][Full Text] [Related]
11. KiSS1 gene as a novel mediator of TGFβ-mediated cell invasion in triple negative breast cancer.
Tian J; Al-Odaini AA; Wang Y; Korah J; Dai M; Xiao L; Ali S; Lebrun JJ
Cell Signal; 2018 Jan; 42():1-10. PubMed ID: 28988968
[TBL] [Abstract][Full Text] [Related]
12. An Oncolytic Adenovirus Encoding Decorin and Granulocyte Macrophage Colony Stimulating Factor Inhibits Tumor Growth in a Colorectal Tumor Model by Targeting Pro-Tumorigenic Signals and via Immune Activation.
Liu Z; Yang Y; Zhang X; Wang H; Xu W; Wang H; Xiao F; Bai Z; Yao H; Ma X; Jin L; Wu C; Seth P; Zhang Z; Wang L
Hum Gene Ther; 2017 Aug; 28(8):667-680. PubMed ID: 28530155
[TBL] [Abstract][Full Text] [Related]
13. High tumoral levels of Kiss1 and G-protein-coupled receptor 54 expression are correlated with poor prognosis of estrogen receptor-positive breast tumors.
Marot D; Bieche I; Aumas C; Esselin S; Bouquet C; Vacher S; Lazennec G; Perricaudet M; Kuttenn F; Lidereau R; de Roux N
Endocr Relat Cancer; 2007 Sep; 14(3):691-702. PubMed ID: 17914099
[TBL] [Abstract][Full Text] [Related]
14. A targeting ligand enhances infectivity and cytotoxicity of an oncolytic adenovirus in human pancreatic cancer tissues.
Yamamoto Y; Hiraoka N; Goto N; Rin Y; Miura K; Narumi K; Uchida H; Tagawa M; Aoki K
J Control Release; 2014 Oct; 192():284-93. PubMed ID: 25108153
[TBL] [Abstract][Full Text] [Related]
15. Cancer-specific targeting of a conditionally replicative adenovirus using mRNA translational control.
Stoff-Khalili MA; Rivera AA; Nedeljkovic-Kurepa A; DeBenedetti A; Li XL; Odaka Y; Podduturi J; Sibley DA; Siegal GP; Stoff A; Young S; Zhu ZB; Curiel DT; Mathis JM
Breast Cancer Res Treat; 2008 Mar; 108(1):43-55. PubMed ID: 17508279
[TBL] [Abstract][Full Text] [Related]
16. Adenovirus-mediated ING4/IL-24 double tumor suppressor gene co-transfer enhances antitumor activity in human breast cancer cells.
Zhao Y; Li Z; Sheng W; Miao J; Yang J
Oncol Rep; 2012 Oct; 28(4):1315-24. PubMed ID: 22842937
[TBL] [Abstract][Full Text] [Related]
17. KISS1 in breast cancer progression and autophagy.
Ulasov IV; Borovjagin AV; Timashev P; Cristofanili M; Welch DR
Cancer Metastasis Rev; 2019 Sep; 38(3):493-506. PubMed ID: 31705228
[TBL] [Abstract][Full Text] [Related]
18. A heparan sulfate-targeted conditionally replicative adenovirus, Ad5.pk7-Delta24, for the treatment of advanced breast cancer.
Ranki T; Kanerva A; Ristimäki A; Hakkarainen T; Särkioja M; Kangasniemi L; Raki M; Laakkonen P; Goodison S; Hemminki A
Gene Ther; 2007 Jan; 14(1):58-67. PubMed ID: 16900223
[TBL] [Abstract][Full Text] [Related]
19. Survivin-driven and fiber-modified oncolytic adenovirus exhibits potent antitumor activity in established intracranial glioma.
Ulasov IV; Zhu ZB; Tyler MA; Han Y; Rivera AA; Khramtsov A; Curiel DT; Lesniak MS
Hum Gene Ther; 2007 Jul; 18(7):589-602. PubMed ID: 17630837
[TBL] [Abstract][Full Text] [Related]
20. A combinational therapy of EGFR-CAR NK cells and oncolytic herpes simplex virus 1 for breast cancer brain metastases.
Chen X; Han J; Chu J; Zhang L; Zhang J; Chen C; Chen L; Wang Y; Wang H; Yi L; Elder JB; Wang QE; He X; Kaur B; Chiocca EA; Yu J
Oncotarget; 2016 May; 7(19):27764-77. PubMed ID: 27050072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
